Integrated Advisors Network’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,117
Closed -$749K 675
2023
Q3
$749K Sell
5,117
-5,348
-51% -$815K 0.05% 332
2023
Q2
$1.6M Sell
10,465
-455
-4% -$71K 0.09% 222
2023
Q1
$1.69M Sell
10,920
-1,215
-10% -$191K 0.1% 203
2022
Q4
$1.87M Sell
12,135
-443
-4% -$65.4K 0.12% 190
2022
Q3
$1.66M Buy
+12,578
New +$1.76M 0.11% 189
2022
Q2
Sell
-12,539
Closed -$1.87M 684
2022
Q1
$1.87M Buy
12,539
+5,509
+78% +$815K 0.11% 204
2021
Q4
$1.14M Buy
7,030
+1,545
+28% +$250K 0.07% 257
2021
Q3
$911K Buy
5,485
+422
+8% +$72.1K 0.06% 280
2021
Q2
$874K Buy
+5,063
New +$836K 0.06% 241

Other funds holding FBT

Integrated Advisors Network's FBT Position: Q4 2023 in Review

Integrated Advisors Network sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2023, closing a stake of 5,117 shares — an estimated $749K sold.

Integrated Advisors Network first reported a position in FBT in Q2 2021 and held it in 9 quarters. The position peaked at $1.87M in Q4 2022. 257 funds tracked by Wall St. Rank hold FBT as of Q4 2023.

  • Integrated Advisors Network reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2023 after selling out during the quarter.
  • Integrated Advisors Network sold 5,117 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2023, an estimated $749K.
  • Integrated Advisors Network first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2021 and held it in 9 quarters.
  • Integrated Advisors Network's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.87M in Q4 2022.
  • 257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2023.

Based on Integrated Advisors Network's 13F filing for Q4 2023, filed 26 Feb 2024.